Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NovoCure Limited

    NASDAQ: NVCR · Real-Time Price · USD
    17.89
    0.34 (1.94%)
    At close: Jun 16, 2025, 3:59 PM
    17.91
    0.08%
    After-hours: Jun 16, 2025, 06:00 PM EDT

    NovoCure Statistics

    Share Statistics

    NovoCure has 111.49M shares outstanding. The number of shares has increased by 2.14% in one year.

    Shares Outstanding

    n/a
    		 111.49M

    Shares Change (YoY)

    n/a
    		 2.14%

    Shares Change (QoQ)

    n/a
    		 1.58%

    Owned by Institutions (%)

    n/a
    		 84.62%

    Shares Floating

    n/a
    		 98.79M

    Failed to Deliver (FTD) Shares

    n/a
    		 621

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 4.64M, so 4.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.64M

    Short % of Shares Out

    n/a
    		 4.16%

    Short % of Float

    n/a
    		 6.59%

    Short Ratio (days to cover)

    n/a
    		 4.69

    Valuation Ratios

    The PE ratio is -19.06 and the forward PE ratio is -10.02. NovoCure's PEG ratio is 0.95.

    PE Ratio

    n/a
    		 -19.06

    Forward PE

    n/a
    		 -10.02

    PS Ratio

    n/a
    		 5.31

    Forward PS

    n/a
    		 1.7

    PB Ratio

    n/a
    		 8.92

    P/FCF Ratio

    n/a
    		 -46.42

    PEG Ratio

    n/a
    		 0.95
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for NovoCure.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.9.

    Current Ratio

    n/a
    		 1.46

    Quick Ratio

    n/a
    		 1.42

    Debt / Equity

    n/a
    		 1.9

    Debt / EBITDA

    n/a
    		 -6.31

    Debt / FCF

    n/a
    		 -9.87

    Interest Coverage

    n/a
    		 -16.48

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $406,733.87

    Profits Per Employee

    n/a
    		 $-113,324.6

    Employee Count

    n/a
    		 1,488

    Asset Turnover

    n/a
    		 0.49

    Inventory Turnover

    n/a
    		 3.91

    Taxes

    Income Tax

    n/a
    		 37.47M

    Effective Tax Rate

    n/a
    		 -28.56%

    Stock Price Statistics

    The stock price has increased by -7.78% in the last 52 weeks. The beta is 0.75, so NovoCure's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.75

    52-Week Price Change

    n/a
    		 -7.78%

    50-Day Moving Average

    n/a
    		 17.46

    200-Day Moving Average

    n/a
    		 20.21

    Relative Strength Index (RSI)

    n/a
    		 51.03

    Average Volume (20 Days)

    n/a
    		 1,060,347

    Income Statement

    In the last 12 months, NovoCure had revenue of 605.22M and earned -168.63M in profits. Earnings per share was -1.56.

    Revenue

    n/a
    		 605.22M

    Gross Profit

    n/a
    		 468.04M

    Operating Income

    n/a
    		 -170.5M

    Net Income

    n/a
    		 -168.63M

    EBITDA

    n/a
    		 -108.26M

    EBIT

    n/a
    		 -120.82M

    Earnings Per Share (EPS)

    n/a
    		 -1.56
    Full Income Statement

    Balance Sheet

    The company has 163.77M in cash and 683.35M in debt, giving a net cash position of -519.59M.

    Cash & Cash Equivalents

    n/a
    		 163.77M

    Total Debt

    n/a
    		 683.35M

    Net Cash

    n/a
    		 -519.59M

    Retained Earnings

    n/a
    		 -1.15B

    Total Assets

    n/a
    		 1.25B

    Working Capital

    n/a
    		 346M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -26.37M and capital expenditures -42.85M, giving a free cash flow of -69.22M.

    Operating Cash Flow

    n/a
    		 -26.37M

    Capital Expenditures

    n/a
    		 -42.85M

    Free Cash Flow

    n/a
    		 -69.22M

    FCF Per Share

    n/a
    		 -0.64
    Full Cash Flow Statement

    Margins

    Gross margin is 77.33%, with operating and profit margins of -28.17% and -27.86%.

    Gross Margin

    n/a
    		 77.33%

    Operating Margin

    n/a
    		 -28.17%

    Pretax Margin

    n/a
    		 -21.67%

    Profit Margin

    n/a
    		 -27.86%

    EBITDA Margin

    n/a
    		 -17.89%

    EBIT Margin

    n/a
    		 -28.17%

    FCF Margin

    n/a
    		 -11.44%

    Dividends & Yields

    NVCR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NVCR is $32, which is 78.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32

    Price Target Difference

    n/a
    		 78.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.65

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist